XTL Biopharmaceuticals Ltd. (FRA:H2K2)

XTL Biopharmaceuticals Revenue

In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K USD. XTL Biopharmaceuticals had revenue of $289.00K in the quarter ending December 31, 2024.

• Revenue: $451.00K
• Revenue Growth: n/a
• P/S Ratio: 17.08
• Revenue / Employee: $45.10K
• Employees: 10
• Market Cap: 7.44M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	5.94M	5.03M	554.91%
Dec 31, 2007	907.00K	453.00K	99.78%
Dec 31, 2006	454.00K	-2.74M	-85.80%
Dec 31, 2005	3.20M	-	-